Elekta (OTCMKTS:EKTAY) Shares Gap Up – What’s Next?

Elekta AB (OTCMKTS:EKTAY) shares gapped up before the market opened on Monday . The stock had previously closed at $5.12, but opened at $5.40. Elekta shares last traded at $5.39, with a volume of 380 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Elekta presently has an average rating of “Reduce”.

Elekta Trading Up 0.9%

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The firm has a market cap of $2.01 billion, a PE ratio of -34.12 and a beta of 1.01. The company’s 50 day moving average price is $5.15 and its 200 day moving average price is $5.77.

Elekta (OTCMKTS:EKTAY) last announced its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The firm had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. As a group, analysts forecast that Elekta AB will post 0.43 EPS for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.